Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Greipp

Showing results (121-130 of 178) with videos related to

Pageof 18
Sort By:
Cytometry|January 1, 1990
Effect of sonication on paraffin-embedded tissue preparation for DNA flow cytometryN J Gonchoroff, J J Ryan, T K Kimlinger, et al.
Current Topics in Microbiology and Immunology|January 1, 1995
Molecular and biological role of CD40 in multiple myelomaJ J Westendorf, G J Ahmann, J A Lust, et al.
British Journal of Haematology|June 10, 2000
Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patientsR Fonseca, M C Trendle, T Leong, et al.
British Journal of Haematology|April 1, 1986
A monoclonal antibody reactive with a subset of human plasma cellsN J Gonchoroff, J A Katzmann, J P Garton, et al.
Cancer|September 24, 1999
The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486M M Oken, T Leong, R E Lenhard, et al.
Cancer Genetics and Cytogenetics|August 25, 1999
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myelomaS V Rajkumar, R Fonseca, G W Dewald, et al.
Mayo Clinic Proceedings|September 1, 1984
Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heartL Cueto-Garcia, A J Tajik, R A Kyle, et al.
Leukemia|April 27, 2007
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cellsM P Kline, S V Rajkumar, M M Timm, et al.
Leukemia & Lymphoma|February 1, 1996
Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myelomaM M Oken, R A Kyle, P R Greipp, et al.
Blood|June 22, 2001
Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patientsN E Kay, T L Leong, N Bone, et al.
Pageof 18

Showing results (121-130 of 178) with videos related to

Sort By:
Pageof 18
Cytometry|January 1, 1990
Effect of sonication on paraffin-embedded tissue preparation for DNA flow cytometryN J Gonchoroff, J J Ryan, T K Kimlinger, et al.
Current Topics in Microbiology and Immunology|January 1, 1995
Molecular and biological role of CD40 in multiple myelomaJ J Westendorf, G J Ahmann, J A Lust, et al.
British Journal of Haematology|June 10, 2000
Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patientsR Fonseca, M C Trendle, T Leong, et al.
British Journal of Haematology|April 1, 1986
A monoclonal antibody reactive with a subset of human plasma cellsN J Gonchoroff, J A Katzmann, J P Garton, et al.
Cancer|September 24, 1999
The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486M M Oken, T Leong, R E Lenhard, et al.
Cancer Genetics and Cytogenetics|August 25, 1999
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myelomaS V Rajkumar, R Fonseca, G W Dewald, et al.
Mayo Clinic Proceedings|September 1, 1984
Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heartL Cueto-Garcia, A J Tajik, R A Kyle, et al.
Leukemia|April 27, 2007
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cellsM P Kline, S V Rajkumar, M M Timm, et al.
Leukemia & Lymphoma|February 1, 1996
Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myelomaM M Oken, R A Kyle, P R Greipp, et al.
Blood|June 22, 2001
Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patientsN E Kay, T L Leong, N Bone, et al.
Pageof 18